Incidence, Impact and Mechanisms of Perioperative Right VEntricular Dysfunction (IMPRoVE)

Not yet recruitingOBSERVATIONAL
Enrollment

175

Participants

Timeline

Start Date

April 30, 2023

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Right Ventricular Dysfunction
Interventions
DIAGNOSTIC_TEST

Echocardiography

Echocardiography will be performed by BSE accredited echocardiographers in all 175 patients preoperatively and on day 2-4 postoperatively.

DIAGNOSTIC_TEST

T1 Cardiovascular Magnetic Resonance

T1 CMR will be performed in 10 patients from each of the 5 surgical groups (50 patients in total) preoperatively and on day 2-4 postoperatively.

DIAGNOSTIC_TEST

Right heart catheterisation and coronary sinus blood sampling

10 patients from the thoracic surgical group will undergo right heart catheterisation and coronary sinus blood sampling.

Trial Locations (3)

Unknown

Golden Jubilee National Hospital, Clydebank

G4 0SF

Glasgow Royal Infirmary, Glasgow

G51 4TF

Queen Elizabeth University Hospital, Glasgow

All Listed Sponsors
collaborator

University of Glasgow

OTHER

collaborator

NHS Greater Glasgow and Clyde

OTHER

collaborator

Royal London Hospital

UNKNOWN

lead

NHS National Waiting Times Centre Board

OTHER

NCT05827315 - Incidence, Impact and Mechanisms of Perioperative Right VEntricular Dysfunction (IMPRoVE) | Biotech Hunter | Biotech Hunter